Jagdish Kathwate
MD Pediatrics. Assistant Professor, Government Medical College, Aurangabad, India.
First Created: 12/21/2000  Last Updated: 08/01/2015

Patient Education

What is Asthma?

Asthma is a chronic disorder that causes spasm of the airway leading to narrowing of the air passage and attacks of cough, wheeze, and breathlessness. The spasm may occur due to exposure to allergens, chemical irritants, smoke, cold air, and exercise.

What is the Incidence of Asthma?

Asthma tends to affect about 10% of children globally. Why certain patients are susceptible to asthma is still not known.

Asthma due to allergy may also be associated with eczema, allergic rhinitis, and allergic conjunctivitis. Also, allergic predisposition tends to run in families with inheritance between 40-60%. Thus, though allergic predisposition may be inherited, its manifestations may differ between parent and child.

What is the Outcome of Asthma in Childhood?

Wheezing in the 1st 3 years on life is usually benign and is due to small airways in early life. As the airways grow, these children may become less prone to wheezing during viral infections. However, asthma due to allergic inheritance may persist later in life. Also, severe asthma may also persist in adult life.

How Does Asthma Present in a Child?

In children, rather than wheezing and breathlessness, cough is the predominant symptom. The cough may recurrent and may get aggravated during sleep and exercise.

How is Childhood Asthma Diagnosed?

Asthma in children is mainly a clinical diagnosis. The following symptoms may be suggestive of asthma:

Recurrent episodes of wheezing

Recurrent cough - more troublesome at night

Cough or wheeze after exercise

Breathing problems during a particular season

Cough or wheeze after exposure to dust, smoke, perfume, animal fur

Child’s cold frequently affecting the chest and takes more than 10 days to resolve

Symptoms relieved with nebulization.

Your doctor may look for wheeze, signs of respiratory distress, associated allergic conditions such as eczema, rhinitis and hay fever. The child’s lung function may be estimated by an instrument called spirometry or peak expiratory flow meter that will measure the peak expiratory flow rate (PEFR). PEFR increases by >15% in children with asthma after treatment with bronchodilators.

However, there are certain conditions that may mimic asthma such as reflux, cardiac diseases, cystic fibrosis, immunodeficiency, sinusitis, and even a foreign body aspiration. But these can be ruled out by associated symptoms and clinical examination.

What is Treatment for Asthma in Children?

The main aspect of treatment is to ensure proper control of asthma. The aim of therapy is to achieve the best quality of life and minimize symptoms. Thus the goals of asthma care are:

Freedom from symptoms, acute attacks, frequent school absences, and maintaining normal daily activities, sports participation, and growth.

What Happens If Asthma is Not Properly Controlled?

If asthma is not properly controlled, it may lead to impoverished quality of life, repeated attacks which may be life-threatening, poor growth, and limitation of physical activities.

What are Drugs Used to Treat Asthma?

The drugs used to treat asthma fall into 2 broad categories:

  • Relievers - that relieve the acute symptom
  • Preventers - that prevent the acute attack.
  • Patients with persistent asthma require treatment with preventers such as inhaled steroids, long-acting bronchodilators, and other newer drugs such as montelukast which needs to taken daily on a long term basis.

    Patients with acute attacks need to be treated in a hospital and require treatment with inhaled bronchodilators such as salbutamol and oral/IV steroids for the acute episode.

    What is Inhaled Therapy?

    Metered Dose Inhaler (MDI/Pumps): A suspension of the drug (either solid particles or liquid droplets) in a gaseous medium forms a drug aerosol. This aerosol is available as a metered-dose inhaler (MDI) that delivers a fixed amount of medication each time it is activated.

    How to Use a Metered Dose Inhaler?

    • Remove the mouthpiece cover and shake the inhaler
    • Place the mouthpiece in the mouth between the teeth and seal lips around it, taking care not to bite
    • While breathing in slow and deep, press the canister and continue to inhale deeply
    • Remove the inhaler from the mouth and hold the breath for about 10 seconds
    • May repeat another inhalation after one minute.

    In children, inhalation from an MDI directly may be difficult, as it requires hand-mouth co-ordination. Spacer devices are available that aid in such a situation. The spacer is attached to the MDI and the children inhale from the spacer without having hand-mouth co-ordination. In small children babies (children below 3 years), who cannot inhale through a mouthpiece, a facemask is attached to the end of the spacer.

    How to Use a Spacer?

    • Assemble the spacer
    • Shake the inhaler. Insert the inhaler into the spacer
    • Place the mouthpiece of the spacer in the child’s mouth
    • Encourage the child to breathe in and out slowly and gently. (This will make a clicking sound as the valve opens and closes). Once the breathing is established normally, depress the canister while the child continues to breathe several times

    • Remove the device from the child’s mouth.

    Dry Powder Inhalers (DPI/Rotahaler): A capsule of the drug is inserted in a rotahaler device and broken into two halves. The patient inhales the powder through the mouthpiece. Other dry powder devices available are Diskhalers, Spinhalers, Turbohalers, etc.

    Which is the Best Inhaler That Can Be Used?

    The device best for a patient depends on:

    1. Age, level of comprehension and understanding
    2. Cost of the therapy
    3. Side effects of the drugs used

    Thus, individual requirements differ, and a device is selected according to a particular patient’s requirements.

    How is Asthma Prevented?

    Exposure to allergens, smoke, house dust mite, fungi, pollen, pets, upholstered furniture, soft toys should be reduced. Reducing cockroach infestation is advisable. Coloring agents and artificial preservatives in food items should be avoided.

    Can Asthma Be Cured?

    No, asthma cannot be cured. Some children may outgrow asthma if it starts too early in life. However, asthma can be well controlled if proper precautions and treatment are undertaken.

    1. National Asthma Education and Prevention Program, Expert Panel Report II. Guidelines for the diagnosis and management of asthma. NIH publication 97-4051, April, 1997.
    2. Colasurdo GN, Larsen GL: Airway hyperresponsiveness. In: Busse W, Holgate S, eds. Asthma and Rhinitis. Boston, Blackwell Scientific Publications, Inc., 1994, pp 1044-1056.
    3. Martinez FD, Wright AL, Taussig LM, et al: Asthma and wheezing in the first six years of life. N Engl J Med 332:133-138, 1995.
    4. Sears MR, Rea HH, Fenwick J, et al: Deaths from asthma in New Zealand. Arch Dis Child 61:6-10, 1986.
    5. Pedersen S, O'Byrne P: A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 52(suppl 39):1-34, 1997.
    6. Drazen JM, Israel E, O'Byrne PM: Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340:197-206, 1999.
    7. Wenzel SE: New approaches to anti-inflammatory therapy for asthma. Am J Med 104:287-300, 1998.
    8. Knorr B, Matz J, Bernstein JA, et al: Montelukast for chronic asthma in 6- to 14-year-old children. A randomized, double-blind trial. JAMA 279:1181-1186, 1998.
    9. Kemp JP, Dockhorn RJ, Shapiro GG, et al: Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma. J Pediatr 133:424-428, 1998.
    10. de Jong VM, Janssens HM, Heijnen EMEW, et al: Spacer handling and variability of aerosol delivery in wheezy infants [Session A41]. ALA/ATS International Conference, San Diego, Ca, 1999.
    11. Janssens HM, Heijnen EMEW, de Jong VM, et al: Variability of aerosol delivery via spacer devices in wheezy infants in daily life [Session A41]. ALA/ATS International Conference, San Diego, Ca, 1999.
    12. Heijnen EMEW, Janssens HM, de Jong VM, et al: Spacers and electrostatic charge in daily life [Session A41]. ALA/ATS International Conference, San Diego, Ca, 1999.
    13. Roorda RJ, Mezei G, Bisgaard H, et al: Response of pre-school children with asthma symptoms to inhaled fluticasone propionate: results from two multicenter studies [Session A41]. ALA/ATS International Conference, San Diego, Ca, 1999.
    14. Mandelberg A, Tsehori S, Houri S, et al: Nebulized aerosol treatment in the pediatric emergency department — is it essential? Comparison with a metal spacer device for MDI [Session A41]. ALA/ATS International Conference, San Diego, Ca, 1999.
    15. Lampl KL, Dixon SJ, Bonuccelli CM: Long-term safety and efficacy of zafirlukast (Accolate) in pediatric patients with mild-to-moderate asthma [Session A41]. ALA/ATS International Conference, San Diego, Ca, 1999.
    16. British Asthma Guidelines Coordination Committee. British guidelines on asthma management: 1995 review and position statement. Thorax 1997; 52: S1-24.
    17. Keeley D, Rees J. New guidelines on asthma management. Br Med J 1997 Feb 1; 314: 315-6.

    Asthma Asthma 2015-08-01
    Disclaimer: The information given by is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
    0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0